Tokyo, Jan. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060507) titled 'Developing a scale to assess the psychosocial impact of comprehensive cancer genomic profiling testing' on Jan. 29.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Institute for Cancer Control
Condition:
Condition - Advanced cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to evaluate the validity and reliability of the Multidimensional Impact of Cancer Risk Assessment for Comprehensive Genomic Profiling (MICRA-CGP), a scale developed to assess the psychosocial impact following the disclosure o...